Review

Published on 10 Nov 2021

Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma

in Cancer Molecular Targets and Therapeutics

Shansa Pranami E. Jayaweera
Sacheela Prasadi Wanigasinghe Kanakanamge
Dharshika Rajalingam
Gayathri N. Silva

Frontiers in Oncology

doi 10.3389/fonc.2021.740796

17,412 views
51 citations

Original Research

Published on 09 Nov 2021

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma

in Cancer Molecular Targets and Therapeutics

Shuai Li
Jingyuan Zhao
Linlin Lv
Deshi Dong

Frontiers in Oncology

doi 10.3389/fonc.2021.762821

3,567 views
5 citations

Original Research

Published on 08 Nov 2021

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma

in Cancer Molecular Targets and Therapeutics

Wenjian Yao
Jianjun Wang
Li Zhu
Xiangbo Jia
Lei Xu
Xia Tian
Shuai Hu
Sen Wu
Li Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.761346

3,086 views
10 citations

Original Research

Published on 05 Nov 2021

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma

in Cancer Molecular Targets and Therapeutics

Hao Wang
Lei Shi
Zhimin Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.756817

2,792 views
8 citations

Review

Published on 05 Nov 2021

Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer

in Cancer Molecular Targets and Therapeutics

Yu Zhang
Yi-Jing Wei
Yi-Fei Zhang
Hao-Wen Liu
Yin-Feng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.765458

3,779 views
26 citations

Review

Published on 05 Nov 2021

Current Strategies for Cancer Cell-Derived Extracellular Vesicles for Cancer Therapy

in Cancer Molecular Targets and Therapeutics

Xiaolin Gong

Frontiers in Oncology

doi 10.3389/fonc.2021.758884

3,567 views
4 citations

Original Research

Published on 03 Nov 2021

miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer

in Cancer Molecular Targets and Therapeutics

Yu Mei
Kai Li
Zhicheng Zhang
Mengmeng Li
Hong Yang
Hui Wang
Xuemei Huang
Xinyuan Li
Shuhua Shi
Huanjie Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.740452

2,412 views
8 citations

Original Research

Published on 02 Nov 2021

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer

in Cancer Molecular Targets and Therapeutics

Zequn Li
Yuqi Sun
Jianfei Xu
Hao Yang
Xiaodong Liu
Yulong Tian
Shougen Cao
Yanbing Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.770997

3,226 views
11 citations

Original Research

Published on 01 Nov 2021

Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs

in Cancer Molecular Targets and Therapeutics

Hanna Cho
Namkyoung Kim
Takashi Murakami
Taebo Sim

Frontiers in Oncology

doi 10.3389/fonc.2021.757598

4,037 views
5 citations

Original Research

Published on 01 Nov 2021

Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome

in Cancer Molecular Targets and Therapeutics

Muhanad Alhujaily
Hafsa Abbas
Mingzhan Xue
Alberto de la Fuente
Naila Rabbani
Paul J. Thornalley

Frontiers in Oncology

doi 10.3389/fonc.2021.748698

4,088 views
16 citations

Review

Published on 29 Oct 2021

Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review

in Cancer Molecular Targets and Therapeutics

Konstantina Kitsou
Maria Iliopoulou
Vana Spoulou
Pagona Lagiou
Gkikas Magiorkinis

Frontiers in Oncology

doi 10.3389/fonc.2021.687631

7,695 views
14 citations

Systematic Review

Published on 28 Oct 2021

BRCA1 Versus BRCA2 and PARP Inhibitors Efficacy in Solid Tumors:A Meta-Analysis of Randomized Controlled Trials

in Cancer Molecular Targets and Therapeutics

Shan Li
Li Tao
Haiyun Dai
Xue Gong
Yuguo Zhuo
Hui Xiang
Yueyang Zhao
Qing Gao
Liang Deng

Frontiers in Oncology

doi 10.3389/fonc.2021.718871

5,117 views
7 citations

Original Research

Published on 27 Oct 2021

IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors

in Cancer Molecular Targets and Therapeutics

Guangchao Li
Qing Zhang
Zeping Han
Yangmin Zhu
Huijuan Shen
Zhi Liu
Zhao Zhou
Wen Ding
Siqi Han
Jinhua He

Frontiers in Oncology

doi 10.3389/fonc.2021.734593

6,321 views
19 citations

Original Research

Published on 26 Oct 2021

The Anti-Colon Cancer Effects of Essential Oil of Curcuma phaeocaulis Through Tumour Vessel Normalisation

in Cancer Molecular Targets and Therapeutics

Yewen Feng
Lu Deng
Hengrui Guo
Yumin Zhao
Fu Peng
Gang Wang
Chenghao Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.728464

3,811 views
8 citations

Original Research

Published on 26 Oct 2021

Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer

in Cancer Molecular Targets and Therapeutics

Po-Fu Yueh
Yuan-Hao Lee
I-Tsang Chiang
Wei-Ting Chen
Keng-Li Lan
Cheng-Hsien Chen
Fei-Ting Hsu

Frontiers in Oncology

doi 10.3389/fonc.2021.735183

4,780 views
19 citations

Editorial

Published on 25 Oct 2021

Editorial: Nanomedicine in Cancer Targeting and Therapy

in Cancer Molecular Targets and Therapeutics

João Paulo Figueiró Longo
Luis Alexandre Muehlmann
Marcelo Calderón
Christian Stockmann
Ricardo Bentes Azevedo

Frontiers in Oncology

doi 10.3389/fonc.2021.788210

1,777 views
5 citations

Navigation group

Articles

Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma

Emerging Functions and Clinical Applications of Exosomal ncRNAs in Ovarian Cancer

Current Strategies for Cancer Cell-Derived Extracellular Vesicles for Cancer Therapy

miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer

Anti-Tumor Activity of AZD4547 Against NTRK1 Fusion Positive Cancer Cells Through Inhibition of NTRKs

Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome

Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review

BRCA1 Versus BRCA2 and PARP Inhibitors Efficacy in Solid Tumors:A Meta-Analysis of Randomized Controlled Trials

IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors

The Anti-Colon Cancer Effects of Essential Oil of Curcuma phaeocaulis Through Tumour Vessel Normalisation

Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer

Editorial: Nanomedicine in Cancer Targeting and Therapy